| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Revenue  | 138 | 144 | 144 | 127 | 168 | 161 | 192 | 221 | 242 | 218 | 277 | 287 |
| Expenses | 129 | 132 | 138 | 138 | 158 | 150 | 169 | 193 | 203 | 186 | 218 | 231 |
| EBITDA | 9 | 13 | 6 | -11 | 11 | 11 | 24 | 29 | 40 | 32 | 59 | 56 |
| Operating Profit % | 6 % | 8 % | 4 % | -9 % | 6 % | 5 % | 10 % | 12 % | 14 % | 11 % | 19 % | 20 % |
| Depreciation | 3 | 3 | 2 | 0 | 1 | 1 | 1 | 2 | 1 | 2 | 8 | 9 |
| Interest | 5 | 5 | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
| Profit Before Tax | 2 | 4 | 14 | -12 | 9 | 9 | 22 | 27 | 35 | 30 | 70 | 58 |
| Tax | 1 | 1 | 3 | -0 | 2 | 2 | 5 | 8 | 8 | 7 | 15 | 13 |
| Net Profit | 1 | 3 | 12 | -12 | 7 | 8 | 17 | 19 | 27 | 23 | 55 | 44 |
| EPS in ₹ | 0.45 | 1.24 | 4.53 | -4.41 | 2.75 | 3.00 | 6.51 | 7.20 | 10.20 | 3.40 | 8.26 | 6.40 |
Jagsonpal Pharmaceuticals
Jagsonpal Pharmaceuticals
208.01
-1.78
(-0.85%)
Market Cap
1,391.39 Cr
PE Ratio
32.72
Volume
33,446.00
Day High - Low
211.78 - 205.67
52W High-Low
301.65 - 155.00
Key Fundamentals
Market Cap
1,391.39 Cr
EPS
6.40
PE Ratio
32.72
PB Ratio
5.11
Book Value
41.14
EBITDA
56.00
Dividend Yield
1.90 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
23.07
Debt to Equity
0.04
Actual
Company News
View All News
Jagsonpal Pharmaceuticals launches equity buyback from May 08 to May 14, 2026, with small shareholders entitled to 47 shares for every 637 held on the May 04 record date.
Jagsonpal Pharmaceuticals dispatches Letter of Offer dated May 06, 2026 for ₹40 crore buyback of up to 16,00,000 equity shares at ₹250/share; buyback opens May 8 and closes May 14, 2026.
Jagsonpal Pharmaceuticals reported 7% revenue growth and 19% PAT growth for FY26, declared 200% dividend including 75% special dividend, and announced INR40 crore buyback at INR250/share.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,859.10 | #1 4,46,060.36 | 39.96 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 58.45 | |
6,871.50 | 1,82,416.73 | 72.74 | 9,712.00 | 18.67 | 2,191 | -1.02 | 72.69 | |
4,387.90 | 1,48,506.47 | 63.98 | 11,539.40 | 6.99 | 1,911 | 26.24 | 52.52 | |
1,411.20 | 1,13,994.01 | 27.76 | 27,711.70 | -2.46 | 3,783 | -55.32 | 56.75 | |
1,300.80 | 1,08,570.36 | 25.40 | 33,593.30 | -0.44 | 3,998 | -86.05 | 47.13 | |
2,251.80 | 1,02,916.99 | 18.91 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 38.38 | |
2,431.50 | 1,00,373.55 | 55.11 | 12,744.20 | 20.90 | 2,007 | 7.65 | 67.26 | |
990.40 | 99,657.41 | #1 18.80 | 23,511.00 | 18.55 | 4,615 | -0.32 | 55.29 | |
1,510.90 | 87,753.32 | 24.96 | 32,345.60 | 9.43 | 3,484 | 7.59 | 71.98 | |
1,299.40 | 70,148.96 | 77.65 | 6,812.90 | #1 21.03 | 884 | 21.18 | 76.81 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
3.73 %
Net Income Growth
-19.98 %
Cash Flow Change
57.24 %
ROE
92.41 %
ROCE
81.03 %
EBITDA Margin (Avg.)
-12.57 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 154 | 159 | 143 | 130 | 136 | 147 | 164 | 164 | 195 | 217 | 278 | 317 |
| Fixed Assets | 52 | 52 | 22 | 21 | 22 | 22 | 26 | 23 | 24 | 9 | 95 | 85 |
| Current Assets | 96 | 101 | 110 | 95 | 98 | 95 | 121 | 109 | 165 | 197 | 161 | 143 |
| Capital Work in Progress | 0 | 0 | 0 | 3 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 11 | 15 | 51 | 1 | 0 | 0 | 15 |
| Other Assets | 102 | 108 | 121 | 106 | 110 | 109 | 123 | 91 | 170 | 208 | 184 | 0 |
| Total Equity & Liabilities | 154 | 159 | 143 | 130 | 136 | 147 | 164 | 164 | 195 | 217 | 278 | 317 |
| Current Liabilities | 55 | 57 | 29 | 29 | 28 | 33 | 40 | 27 | 28 | 19 | 26 | 28 |
| Non Current Liabilities | 4 | 4 | 3 | 3 | 3 | 3 | 2 | 5 | 9 | 11 | 12 | 12 |
| Total Equity | 95 | 98 | 110 | 98 | 105 | 111 | 122 | 133 | 159 | 187 | 240 | 276 |
| Reserve & Surplus | 82 | 85 | 97 | 85 | 91 | 98 | 109 | 120 | 146 | 174 | 226 | 263 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 2 | 1 | 5 | -6 | 24 | -1 | 19 | -36 | -12 | 2 | -2 |
| Investing Activities | -1 | -2 | 41 | -3 | -1 | -11 | -2 | -26 | -58 | -25 | -45 |
| Operating Activities | 4 | 9 | -3 | -2 | 31 | 11 | 28 | 7 | 47 | 35 | 55 |
| Financing Activities | -1 | -6 | -34 | -1 | -6 | -1 | -7 | -18 | -1 | -9 | -12 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 70.34 % | 70.34 % | 70.34 % | 70.34 % | 68.71 % | 68.71 % | 68.71 % | 68.71 % | 68.71 % | 68.71 % | 68.71 % | 68.48 % | 68.09 % | 68.04 % | 67.97 % | 67.81 % | 67.78 % | 67.65 % | 67.54 % | 67.39 % | 67.89 % |
| FIIs | 0.00 % | 0.00 % | 0.11 % | 0.20 % | 0.00 % | 0.00 % | 0.13 % | 0.00 % | 0.00 % | 0.00 % | 0.38 % | 0.00 % | 0.73 % | 1.10 % | 2.30 % | 2.10 % | 2.10 % | 2.18 % | 2.12 % | 2.12 % | 2.44 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.28 % | 0.77 % | 0.83 % | 0.83 % | 0.83 % | 0.00 % | 0.85 % | 0.85 % | 0.11 % | 0.00 % | 0.00 % | 0.05 % | 0.09 % | 0.15 % | 0.22 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 26.67 % | 26.08 % | 23.71 % | 23.71 % | 22.92 % | 25.27 % | 22.78 % | 21.11 % | 22.23 % | 22.84 % | 21.99 % | 21.94 % | 20.69 % | 20.79 % | 20.38 % | 20.64 % | 20.94 % | 24.26 % | 21.13 % | 21.20 % | 20.73 % |
| Others | 2.98 % | 3.57 % | 5.83 % | 5.75 % | 8.36 % | 6.02 % | 8.10 % | 9.40 % | 8.23 % | 7.62 % | 8.09 % | 9.58 % | 9.64 % | 9.22 % | 9.24 % | 9.45 % | 9.17 % | 5.86 % | 9.12 % | 9.14 % | 8.71 % |
| No of Share Holders | 0 | 12,546 | 14,655 | 14,353 | 20,031 | 17,100 | 16,194 | 14,952 | 14,084 | 13,782 | 16,041 | 15,785 | 16,282 | 15,748 | 15,633 | 18,471 | 21,085 | 22,899 | 24,653 | 24,895 | 26,264 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.1 | 0.1 | 0.25 | 0.5 | 1 | 4 | 5 | 5 | 2.5 | 0.00 |
| Dividend Yield (%) | 0.93 | 0.95 | 3.56 | 1.57 | 0.8 | 3.45 | 4.52 | 2.3 | 1.36 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 24 Sept 2021 |  Dividend | ₹ 1.00 /share | 22 Sept 2021 | 61.54 | 61.64 |
| 01 Nov 2021 | Dividend | ₹ 4.00 /share | 29 Oct 2021 | 64.98 | 69.88 |
| 17 Jun 2022 |  Extraordinary General Meeting | NA | 17 Jun 2022 | 118.24 | 111.40 |
| 21 Aug 2023 | Dividend | ₹ 5.00 /share | 21 Aug 2023 | 141.58 | 183.34 |
| 06 Sept 2024 | Dividend | ₹ 5.00 /share | 06 Sept 2024 | 144.42 | 167.08 |
| 18 Sept 2024 |  Annual General Meeting | NA | 18 Sept 2024 | 144.54 | 164.02 |
| 23 Oct 2024 |  Quarterly Result Announcement | NA | 23 Oct 2024 | 181.68 | 183.76 |
| 23 Oct 2024 |  Split | 2:5 | 08 Jan 2025 | 183.76 | 183.76 |
| 22 Jan 2025 | Quarterly Result Announcement | NA | 22 Jan 2025 | 215.25 | 222.00 |
| 06 May 2025 | Quarterly Result Announcement | NA | 06 May 2025 | 232.50 | 250.05 |
| 26 Jul 2025 | Quarterly Result Announcement | NA | 26 Jul 2025 | 262.50 | 263.29 |
| 12 Sept 2025 | Dividend | ₹ 2.50 /share | 12 Sept 2025 | 250.05 | 247.82 |
| 24 Sept 2025 | Annual General Meeting | NA | 24 Sept 2025 | 263.29 | 241.89 |
| 03 Nov 2025 | Quarterly Result Announcement | NA | 03 Nov 2025 | 216.10 | 222.84 |
| 21 Jan 2026 | Quarterly Result Announcement | NA | 21 Jan 2026 | 179.00 | 172.17 |
| 27 Apr 2026 | Quarterly Result Announcement | NA | 27 Apr 2026 | 191.94 | 199.45 |
| 08 May 2026 |  Buyback | 250 | 04 May 2026 | 210.05 | 213.35 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
6 days ago
6 days agoSubmission Of Letter Of Offer For Buy-Back Upto 1600000 Equity Shares7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeApr 28, 2026
Apr 28, 2026Corporate Action-Board approves DividendApr 27, 2026
Apr 27, 2026Intimation Of Record Date For The Purpose Of Buy-Back Of Up To 1600000 Fully Paid-Up Equity Shares Of
Face Value ?2/- Each At A Price Of ?250/- Per Share For An Aggregate Amount Not Exceeding ?40 CroresApr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Investor PresentationApr 27, 2026
Apr 27, 2026Corporate Action-Board to consider DividendApr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 27, 2026
Apr 27, 2026Audited Financial Results For The Year Ended March 31 2026Apr 27, 2026
Apr 27, 2026Board Meeting Outcome for Outcome Of Board MeetingApr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 27, 2026
Apr 27, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 27, 2026
Apr 27, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 22, 2026
Apr 22, 2026Board Meeting Intimation for Prior Intimation Of Board Meeting
Apr 20, 2026
Apr 20, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 14, 2026
Apr 14, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 13, 2026
Apr 13, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Apr 10, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 26, 2026
Mar 26, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 25, 2026
Mar 25, 2026Announcement Under Regulation 30 Of Sebi LODRMar 13, 2026
Mar 13, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 12, 2026
Mar 12, 2026Board Meeting Outcome for Outcome Of Board MeetingMar 12, 2026
Mar 12, 2026Board Meeting Intimation for Proposal Of Buyback Of Equity Shares Of The CompanyMar 09, 2026
Mar 09, 2026Announcement Under Regulation 30 Of SEBI LODRMar 09, 2026
Mar 09, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 09, 2026
Mar 09, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 09, 2026
Mar 09, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 27, 2026
Jan 27, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 22, 2026
Jan 22, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 22, 2026
Jan 22, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 21, 2026
Jan 21, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 21, 2026
Jan 21, 2026Outcome Of Board Meeting Held On January 21 2026 Along With Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Jan 21, 2026
Jan 21, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On January 21 2026 Along With Unaudited Financial Results For The
Quarter And Nine Months Ended December 31 2025Jan 21, 2026
Jan 21, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 15, 2026
Jan 15, 2026Board Meeting Intimation for Intimation Of Board MeetingJan 13, 2026
Jan 13, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 06, 2026
Jan 06, 2026Announcement Under Regulation 30 Of SEBI (LODR) 2015Dec 30, 2025
Dec 30, 2025Closure of Trading WindowDec 26, 2025
Dec 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 05, 2025
Dec 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 20, 2025
Nov 20, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 18, 2025
Nov 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 05, 2025
Nov 05, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.03% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 59.13
ATR(14)
Less Volatile 7.97
STOCH(9,6)
Neutral 57.69
STOCH RSI(14)
Oversold 4.73
MACD(12,26)
Bearish -0.12
ADX(14)
Strong Trend 42.05
UO(9)
Bearish 47.28
ROC(12)
Uptrend And Accelerating 5.32
WillR(14)
Neutral -55.03
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
